Exploration of 4-aminopyrrolo[2,3-d]pyrimidine as antitubercular agents

Tuberculosis (TB) is one of the leading causes of death worldwide. Developing new anti-TB compounds using cost-effective processes is critical to reduce TB incidence and accomplish the End TB Strategy milestone. Herein, we describe the synthesis and structure–activity relationships of a library of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Jesumoroti, Omobolanle Janet, Beteck, Richard M., Jordaan, Audrey, Warner, Digby F., Legoabe, Lesetja J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124159/
https://www.ncbi.nlm.nih.gov/pubmed/35598185
http://dx.doi.org/10.1007/s11030-022-10453-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124159/
https://www.ncbi.nlm.nih.gov/pubmed/35598185
http://dx.doi.org/10.1007/s11030-022-10453-1

Ejemplares similares